StocksSanofiSAN.PA

SAN.PA

Sanofi

88.87 -0.11 (-0.12%)
Prices By Xignite, in EUR Market Closed
Trade
S
88.77
B
88.95

Sanofi

Sanofi researches, develops, and markets various therapeutic solutions.
Last Month
60,421
Followers
2.16%
Investors
99% Of them have BUY positions.
A decrease of -0.36% from last trading Day

Related Markets

Centene Corp
CNC
1.22 (1.77%)
S
69.90
B
70.05
Johnson & Johnson
JNJ
-0.88 (-0.53%)
S
164.32
B
164.64
Aurora Cannabis Inc
ACB
-0.32 (-3.32%)
S
9.33
B
9.36
H. Lundbeck A/S
LUN.CO
-1.15 (-0.60%)
S
191.63
B
192.07
Sartorius AG
SRT.DE
-10.00 (-2.49%)
S
390.65
B
392.35
View More
Pinned Post
eToroInvestment
🔵🔴𝗕𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗡𝗲𝘄𝘀 🔴🔵 𝗚𝗦𝗞 𝗔𝗻𝗻𝗼𝘂𝗻𝗰𝗲𝘀 𝗡𝗲𝘄 𝗖𝗼𝘃𝗶𝗱 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗧𝗿𝗶𝗮𝗹 $GSK.L (GlaxoSmithKline) is partnering up with French firm $SAN.PA (Sanofi) to test its own vaccine. GSK’s vaccine progress has been underwhelming, as it has majorly lagged behind its competitors’... Show More
Market Feed
Top
Ondrej Kobza
Czech Republic
Weekly update: we plan to maintain the strategy of investing mainly in high quality and stable stocks from various markets, so the portfolio is continuing to be well diversified and robust with relatively low risk. Last week, we added few new stocks into our portfolio: $MRK (Merck) $AGNC (AGNC Investment... Show More
Andrea Antico
$SAN.PA (Sanofi) June 11, 2021 The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter regarding the supplemental New Drug Application for Aubagio® (teriflunomide) for children and adolescents 10 to 17 years of age with relapsing forms of multiple sclerosis. The FDA deemed the... Show More
Karolis Sakenas
Edited